Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-02 Sale | 2020-11-04 8:31 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 30,000 | $76.22 | $2,286,676 | 51,755 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2023-07-17 4:59 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 0 | $0 | 34,824 (Direct) | View |
Ownership | 2023-07-13 6:40 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 0 | $0 | 30,187 (Direct) | View |
| 2023-05-02 Option Award | 2023-05-04 4:20 pm | N/A 2033-05-02 | Akili Inc. | AKLI | JONES WILLIAM A JR Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-11-02 Option Award | 2022-11-04 6:58 pm | N/A 2032-11-02 | Akili Inc. | AKLI | JONES WILLIAM A JR Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 174,250 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 14,226 | $148.5 | 0 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 2,230 | $123.86 | 80,249 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 8,750 | $0 | 80,249 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:16 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 45,000 | $0 | 80,249 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,631 | $128.87 | 80,249 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:32 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,305 | $115.55 | 11,822 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:32 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 3,000 | $0 | 11,822 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 5,000 | $0 | 82,127 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 8:49 pm | N/A 2031-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 60,000 | $0 | 82,127 (Direct) | View |
| 2021-01-06 Tax Withholding | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 2,124 | $83.38 | 82,127 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 3,000 | $0 | 9,510 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,245 | $90.14 | 9,510 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:31 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 30,000 | $50.72 | 51,755 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:31 pm | N/A 2029-03-31 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 30,000 | $0 | 51,755 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 9:40 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 3,000 | $0 | 10,755 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 9:40 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,245 | $52.13 | 10,755 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 42,000 | $0 | 42,000 (Direct) | View |